Ipramid is a preperation of Ipratropium bromide which is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. It is used in treating chronic obstructive pulmonary disease associated with chronic bronchitis and emphysema. In chronic obstructive pulmonary disease, cholinergic nerves going to the lungs cause narrowing of the bronchi by stimulating the muscles surrounding the bronchi to contract. An “anti-cholinergic” effect of ipratropium bromide blocks the effect of the cholinergic nerves, causing the muscles to relax and the bronchi to dilate.
Adults: The usual dose is 1-2 puffs (20 µg/puff) three or four times daily. Single dose up to 80 µg (4 puffs) may be required to obtain maximum benefit during early treatment. Patients may take additional inhalations as required: however, the total
number of inhalations should not exceed 12 puffs in 24 hours.
6-12 years: Usually 1-2 puffs two to three times dally.
Bellow 6 years: The usual dose is 1 puff (20 µg) three times daily.
In order to ensure that the inhaler is used correctly, administration should be supervised by an adult.
No specific information on the use of the product in the elderly is available. Clinical trials have included patients over 65 years and no adverse reactions specific to this age group have been reported.